Sacubitril/valsartan: um importante avanço no puzzle terapêutico da insuficiência cardíaca-Reference-Cited by-同舟云学术

Sacubitril/valsartan: um importante avanço no puzzle terapêutico da insuficiência cardíaca

Published:2017-09 Issue:9 Volume:36 Page:655-668
ISSN:0870-2551
Container-title:Revista Portuguesa de Cardiologia
language:pt
Short-container-title:Revista Portuguesa de Cardiologia

Author:

Marques da Silva Pedro,Aguiar Carlos

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference56 articles.

1. Direcção‐Geral da Saúde. Portugal – Doenças cérebro‐cardiovasculares em números – 2015. Direcção‐Geral da Saúde, Direção de Serviços de Informação e Análise, fevereiro de 2016.

2. The role of neprilysin inhibitors in cardiovascular disease;Mills;Curr Heart Fail Rep.,2015

3. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

4. EPICA Investigators Prevalence of chronic heart failure in Southwestern Europe: the EPICA study;Ceia;Eur J Heart Fail.,2002

5. How patients with heart failure are managed in Portugal;Fonseca;Eur J Heart Fail.,2002

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative renoprotection: Sacubitril/valsartan versus ACEI or ARB -A systematic review and meta-analysis;Tropical Journal of Pharmaceutical Research;2024-03-12

2. Effect of sacubitril-valsartan on left ventricular remodeling and NT-proBNP in patients with heart failure complicated with hypertension and reduced ejection fraction;American Journal of Translational Research;2024

3. Bioanalytical HPLC method with fluorescence detector for determination of Entresto™ when co-administered with ibuprofen and fexofenadine: a pharmacokinetic study;RSC Advances;2024

4. Efficacy and safety of sacubitril/valsartan in heart failure compared to renin–angiotensin–aldosterone system inhibitors: a systematic review and meta-analysis of randomised controlled trials;Archives of Medical Science;2023-01-10

5. Study on the Efficacy of Sacubitril/Valsartan in Patients with Heart Failure with Preserved Ejection Fraction Undergoing Peritoneal Dialysis;Cardiology;2023